Idera Pharmaceuticals, Inc.
(NASDAQ : IDRA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Loading IDRA News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.65%69.851.0%$924.33m
AMGNAmgen Inc.
0.62%173.170.8%$639.72m
BIIBBiogen Inc.
-0.41%288.940.9%$540.40m
CELGCelgene Corporation
2.07%121.121.0%$493.50m
REGNRegeneron Pharmaceuticals, Inc.
-0.49%371.181.9%$343.16m
ALXNAlexion Pharmaceuticals, Inc.
-1.20%128.822.0%$287.09m
ARIAARIAD Pharmaceuticals, Inc.
0.00%23.9813.0%$197.31m
TSROTESARO, Inc.
4.27%190.3615.3%$197.19m
INCYIncyte Corporation
0.26%120.492.3%$169.80m
ILMNIllumina, Inc.
1.28%163.373.9%$156.34m
CLVSClovis Oncology, Inc.
7.22%65.8016.4%$141.36m
VRTXVertex Pharmaceuticals Incorporated
0.72%88.332.6%$140.89m
EXELExelixis, Inc.
2.08%23.125.5%$127.23m
AAgilent Technologies, Inc.
1.53%51.621.7%$115.01m
ACADACADIA Pharmaceuticals Inc.
0.11%39.2619.0%$90.91m

Company Profile

Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company, which is engaged in discovery, development and commercialization of novel nucleic acid therapeutics to treat patients with serious and life-threatening diseases. The company uses two distinct proprietary drug discovery technology platforms to design and develop drug candidates: Toll-like receptor targeting technology and third-generation antisense technology. Idera Pharmaceuticals was founded by Paul C. Zamecnik, Sudhir A. Agrawal and James B. Wyngaarden on May 25, 1989 and is headquartered in Cambridge, MA.